Nearly 40% of English, Welsh Men with Metastatic Prostate Cancer May Not Be Getting Adequate Treatment

Nearly 40% of English, Welsh Men with Metastatic Prostate Cancer May Not Be Getting Adequate Treatment
Nearly 40 percent of men in England and Wales with locally advanced metastatic prostate cancer, or those at high risk of having this condition, may not be getting proper therapy, according to a study by the National Prostate Cancer Audit (NPCA). Instead of receiving radiotherapy or surgery, a considerable percentage of men are offered hormonal treatments without additional radiotherapy or surgery, which is considered to be an under-treatment for advanced prostate cancer. Doctors presented these findings at last month's European Association of Urology conference in London. Prostate cancer is the most common male cancer, with around 400,000 new cases every year in Europe. Great Britain alone reported more than 46,000 new cases of prostate cancer in 2014, leading to more than 11,000 deaths. "Our work shows that up to 40 percent of patients diagnosed with high-risk or locally advanced prostate cancer may not be receiving the best available treatments in combination with hormonal therapy," the study's lead researcher, Arun Sujenthiran, said in a news release. “Future work will explore reasons for this and will also follow the progress of these men to see if their survival has been affected as a result." Various treatments exist for locally advanced prostate cancer. Previous studies showed that radical treatments — which aim at curing prostate cancer and eliminati
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *